PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Make It a Double? Expert Insights on the Role of Dual Immunotherapy Regimens in First-Line NSCLC Treatment
Visit https://www.peervoice.com/PVK860 to view the entire programme with slides. After completing “Make It a Double? Expert Insights on the Role of Dual Immunotherapy Regimens in First-Line NSCLC Treatment”, participants will be able to: Discuss the latest evidence with immunotherapy (IO)-based combinations for first-line non–small-cell lung cancer (NSCLC) treatment; Interpret what these data mean for the management of patients with NSCLC in Canadian clinical practice.